• Vaxart reached a cooperation agreement with a stockholder group, ending a proxy contest tied to the 2026 annual meeting.
• The company will search within 90 days post-meeting for a mutually agreed independent director to appoint to the board.
• The stockholder group withdrew its director nominations under the agreement.
• Board governance changes include new stockholder engagement and clinical and regulatory affairs committees.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Vaxart Inc. published the original content used to generate this news brief on July 01, 2026, and is solely responsible for the information contained therein.